NEW YORK (GenomeWeb) – A French group spearheaded by genomics services provider IntegraGen said today that it would collaborate on a project to develop software to support data interpretation of next-generation sequencing of cancer patients.

The goal of the Interpretation of Clinical Exome (ICE) project is to provide better diagnoses and develop a data-driven approach for identifying targeted treatment options.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.